Avian Flu Treatment Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the avian flu treatment market grown in recent years?
The avian flu treatment market has experienced strong growth in recent years. It is expected to increase from $12.59 billion in 2024 to $13.81 billion in 2025, at a CAGR of 9.7%. Contributing factors include rising demand for avian flu treatments, growing measures to prevent the spread of bird flu, expanded treatment options, higher investment in healthcare infrastructure, and increased demand for poultry consumption.
How is the avian flu treatment market size expected to evolve during the forecast period?
The avian flu treatment market is expected to grow to $19.69 billion by 2029 with a CAGR of 9.3%. This growth is attributed to greater awareness and diagnosis, government initiatives for pandemic preparedness, increased research and development investments, and the need for effective therapeutics for avian influenza. Trends include novel therapeutic approaches, future technological innovations, collaborative research efforts, new business development, and the use of telemedicine for remote consultations.
Get your avian flu treatment market report here!
https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report
Which key drivers are propelling the avian flu treatment market’s growth?
The growing awareness and diagnosis of avian flu are expected to propel the growth of the avian flu treatment market. With the increasing recognition of avian flu and its potential to cause pandemics, early diagnosis and prompt treatment are essential. According to the World Health Organization, over 8,000 people were under active surveillance in the U.S. due to exposure to infected animals between 2022 and 2024. This growing awareness is driving the demand for avian flu treatment.
What are the market segments in the avian flu treatment industry?
The avian flu treatment market covered in this report is segmented –
1) By Type: Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
2) By Distribution Channel: Online Pharmacies, Offline Pharmacies
3) By End User: Hospital, Institutional Health Centers, Clinics
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Tetracycline Antibiotics, Penicillin-Based Antibiotics, Macrolide Antibiotics, Cephalosporins, Antimicrobial Peptides
2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), M2 Ion Channel Inhibitors (Amantadine), Polymerase Inhibitors, Protease Inhibitors, Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp
Which leading companies are shaping the growth of the avian flu treatment market?
Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma
What key trends are currently impacting the avian flu treatment market’s development?
In the avian flu treatment market, companies are forming partnerships to accelerate the development of new treatments. For instance, in April 2024, CureVac N.V., a Germany-based biotechnology company, partnered with GSK plc to develop a pre-pandemic vaccine candidate for the H5N1 avian influenza virus. The Phase 1/2 study will evaluate the safety and effectiveness of the vaccine in healthy adults and older individuals.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16352
Which geographic areas are influencing the growth of the avian flu treatment market?
North America was the largest region in the avian flu treatment market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Wastewater Treatment Equipment Global Market Report 2024
Alzheimer’s Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
Polycystic Ovarian Syndrome Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
